Guidelines

MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis

Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Department of Cancer Studies and Molecular Medicine, MRC Toxicology Unit, University of Leicester, UK
Department of Clinical and Experimental Medicine, Linköping University, Sweden
Department of Hematology, Royal Bournemouth Hospital, UK
Ludwig Institute for Cancer Research, University of Oxford, UK
University Hospital Brno and Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Department of Hematology, University Hospital, University of Duisburg-Essen, Essen, Germany
Laboratory for Immunological and Molecular Cancer Research, University Clinics of Internal Medicine III with Hematology, Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncologic Center, Paracelus Medical University, Salzburg, Austria
Laboratory of B Cell Neoplasia, Division of Molecular Oncology, Ospedale San Raffaele, Istituto Scientifico San Raffale, Fondazione Centro San Raffaele, Università Bita-Salute San Raffaele, Milan, Italy
Institute of Hematology and Oncology, Department of Hematology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden;Department of Biomedical Sciences, Kull Allied Health Sciences, International Islamic University Malaysia, Kuantan, Pahang, Malaysia
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden
Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Department of Cancer Studies and Molecular Medicine, MRC Toxicology Unit, University of Leicester, UK
Department of Clinical and Experimental Medicine, Linköping University, Sweden
Department of Clinical and Experimental Medicine, Linköping University, Sweden
Department of Hematology, Royal Bournemouth Hospital, UK
University Hospital Brno and Central European Institute of Technology, Masaryk University, Brno, Czech Republic
University Hospital Brno and Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Department of Hematology, University Hospital, University of Duisburg-Essen, Essen, Germany
Laboratory for Immunological and Molecular Cancer Research, University Clinics of Internal Medicine III with Hematology, Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncologic Center, Paracelus Medical University, Salzburg, Austria
Department of Internal Medicine III, University of Ulm, Germany
Department of Internal Medicine III, University of Ulm, Germany
Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany;Department of Internal Medicine V, University Hospital Heidelberg, Germany
Vol. 99 No. 8 (2014): August, 2014 https://doi.org/10.3324/haematol.2013.101170